These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Fresh from the pipeline. Ezetimibe. Earl J; Kirkpatrick P Nat Rev Drug Discov; 2003 Feb; 2(2):97-8. PubMed ID: 12572539 [No Abstract] [Full Text] [Related]
29. Synthesis and bioactivities of 2-azetidinone derivatives as cholesterol absorption inhibitors. Wang Y; Qian H; Zhou J; Zhang H; Ji J; Huang W Med Chem; 2011 Nov; 7(6):534-42. PubMed ID: 22313293 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro evaluation of inhibitors of intestinal cholesterol absorption. Kvaernø L; Werder M; Hauser H; Carreira EM J Med Chem; 2005 Sep; 48(19):6035-53. PubMed ID: 16162006 [TBL] [Abstract][Full Text] [Related]
31. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Davis HR; Murgolo NJ; Graziano MP N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677799 [No Abstract] [Full Text] [Related]
33. Sugar-substituted 2-azetidinones as cholesterol absorption inhibitors. Vaccaro WD; Sher R; Davis HR Bioorg Med Chem Lett; 1998 Jan; 8(1):35-40. PubMed ID: 9871624 [TBL] [Abstract][Full Text] [Related]
34. Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Synthesis and hypocholesterolemic activity of dibenz[b,e]oxepin-11-carboxanilides. Kumazawa T; Yanase M; Harakawa H; Obase H; Shirakura S; Ohishi E; Oda S; Kubo K; Yamada K J Med Chem; 1994 Mar; 37(6):804-10. PubMed ID: 8145231 [TBL] [Abstract][Full Text] [Related]
35. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties. Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297 [TBL] [Abstract][Full Text] [Related]
36. Substituted (1,2-diarylethyl)amide acyl-CoA:cholesterol acyltransferase inhibitors: effect of polar groups on in vitro and in vivo activity. Clader JW; Berger JG; Burrier RE; Davis HR; Domalski M; Dugar S; Kogan TP; Salisbury B; Vaccaro W J Med Chem; 1995 May; 38(10):1600-7. PubMed ID: 7752185 [TBL] [Abstract][Full Text] [Related]
37. [The current debate on lowering LDL cholesterol with ezetimibe]. Erdmann E Dtsch Med Wochenschr; 2010 Sep; 135(36):1742. PubMed ID: 20812160 [No Abstract] [Full Text] [Related]
38. Sugar-substituted 2-azetidinone cholesterol absorption inhibitors: enhanced potency by modification of the sugar. Vaccaro WD; Davis HR Bioorg Med Chem Lett; 1998 Feb; 8(3):313-8. PubMed ID: 9871676 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Sudhop T; Lütjohann D; Kodal A; Igel M; Tribble DL; Shah S; Perevozskaya I; von Bergmann K Circulation; 2002 Oct; 106(15):1943-8. PubMed ID: 12370217 [TBL] [Abstract][Full Text] [Related]
40. ACAT inhibitors: the search for a novel and effective treatment of hypercholesterolemia and atherosclerosis. Sliskovic DR; Picard JA; Krause BR Prog Med Chem; 2002; 39():121-71. PubMed ID: 12536672 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]